Additionally, we found that ER(−) breast cancer tissues present increased SPRY4-IT1 expression than ER(+) breast cancer tissues, which lead us to hypothesize that SPRY4-IT1 may be negatively correlated with estradiol. Here, SPRY4 is linked to breast cancer.